BioSpace News Archive

Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical medchem company specializing in the research and development of potent novel monotherapeutics, announced today that the Company’s Chairman & CEO, Dean Petkanas, was featured in an OTCQB podcast discussing the cannabinoid therapeutics industry and its role in eradicating the current opioid epidemic.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Blake Schroeder, CEO of the Company’s subsidiary Kannaway®, was honored as the Top CEO of the Year by the International Association of Top Professionals (IAOTP).

Ariadne Labs’ Serious Illness Care Program recently developed a COVID-19 Response Toolkit to support health systems and clinicians in addressing the communication needs of patients in the community and in the hospital.

In the urgent battle to treat COVID-19 patients, a group of eleven international medical research organizations is investigating whether overactive immune cells that produce Neutrophil Extracellular Traps (NETs) cause the most severe cases

RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, today announced the close of a $100 million equity financing led by Public Sector Pension Investment Board (PSP Investments), one of Canada’s largest pension investment managers that focuses on long-term investments with partners demonstrating strong value orientation strategies.

Stress is a part of life for many of us – especially now more than ever. Whether we are having trouble adjusting to working from home, caring for a sick relative or home-schooling children, it seems everyone is experiencing some form of stress during this global health crisis

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its proprietary VivaGel® active, astodrimer sodium (SPL7013), has been shown in laboratory studies to have significant antiviral activity against the coronavirus that causes COVID-19 (coronavirus disease).

LegoChem Biosciences, Inc. (“LCB”) (KOSDAQ:141080), based in Daejeon, South Korea, announced today that it has entered a research collaboration and license agreement with Iksuda Therapeutics (“Iksuda”) for the development of antibody-drug conjugates in oncology.

OneOncology, the national partnership of independent community oncologists, said today that enrolling patients in clinical trials at its partner practices has slightly increased in March and April just as the COVID-19 pandemic hit our communities hardest.

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has signed an exclusive agreement with Pacific GeneTech, a biologics company that develops and commercializes next-generation vaccines for areas of high unmet or underserved needs in food safety and animal health, to license PGT’s Salmonella vaccine for poultry.